CI - Cigna Group Stock Analysis
Cigna Group (CI) is a publicly traded company listed on the NYSE. It operates in the Healthcare Plans industry, part of the broader Healthcare sector. The company has a market capitalization of 71.70B, generates annual revenue of 268.22B, and reports net income of 6.15B. As of the latest data, the stock is trading at 268.42 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (2.71%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Buy (4.12), indicating current market sentiment. Institutional ownership is reported at 90.34%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -20.36%, trading within a 52-week range of 239.51 - 350.00.
CI - Cigna Group
268.42
Analyst Consensus
Buy 4.12
CI – Analyst Rating Summary
- Strong Buy: 10
- Buy: 18
- Hold: 6
- Sell: 0
- Strong Sell: 0
- Total Analysts: 34
| Index: | S&P 500 | P/E: | 11.84 | EPS (ttm): | 22.67 | Insider Own: | 1.62% | Shs Outstand: | 266.60M | Perf Week: | -3.57% |
| Market Cap: | 71.70B | Forward P/E: | 8.77 | EPS next Y: | 30.61 | Insider Trans: | -0.68% | Shs Float: | 262.79M | Perf Month: | 1.42% |
| Income(ttm): | 6.15B | PEG: | 1.60 | EPS next Q: | 7.89 | Inst Own: | 90.34% | Short Float: | 1.50% | Perf Quarter: | -12.08% |
| Revenue(ttm): | 268.22B | P/S: | 0.27 | EPS this Y: | 8.37% | Inst Trans: | 0.49% | Short Ratio: | 2.05 | Perf Half Y: | -13.70% |
| Book/sh: | 156.81 | P/B: | 1.71 | EPS next Y: | 3.36% | ROA: | 4.01% | Short Interest: | 3.93M | Perf Year: | -20.36% |
| Cash/sh: | - | P/C: | - | EPS next 5Y: | 7.40% | ROE: | 14.65% | 52W Range: | 239.51 - 350.00 | Perf YTD: | -2.80% |
| Dividend Est.: | 7.28 (2.71%) | P/FCF: | 9.64 | EPS past 3/5Y: | -8.32% -2.04% | ROIC: | 8.45% | 52W High: | 350.00 -23.31% | Beta: | 0.27 |
| Dividend TTM: | 6.04 (2.25%) | Quick Ratio: | - | Sales past 3/5Y: | 11.93% 9.71% | Gross Margin: | - | 52W Low: | 239.51 12.07% | Perf 5Y: | 26.32% |
| Dividend Ex-Date: | Dec 04, 2025 | Current Ratio: | 0.83 | EPS Y/Y TTM: | 113.48% | Oper. Margin: | 3.57% | RSI (14): | 43.64 | Volatility: | 1.99% 2.67% |
| Employees: | 73500 | Debt/Eq: | 0.81 | Sales Y/Y TTM: | 16.75% | Profit Margin: | 2.29% | Recom: | 1.46 | Target Price: | 328.30 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.74 | EPS Q/Q: | 165.87% | Payout: | 46.19% | Rel Volume: | 0.73 | Prev Close: | 270.32 |
| Sales Surprise: | 2.95% | EPS Surprise: | 2.49% | Sales Q/Q: | 11.15% | Earnings: | Oct 30 BMO | Avg Volume: | 1.92M | Price: | 268.42 |
| SMA20: | -0.84% | SMA50: | -5.38% | SMA200: | -11.67% | Undervalued: 22.31% | Volume: | 1,409,436 | Change: | -0.70% | |
Graham Classic formula value: 474.31
(P/E=8 * 1g) Min value: 313.49
(current P/E * 2g) Max value: 542.3
Average value: 443.37
About Cigna Group
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.